Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma
Authors
Keywords
-
Journal
VIRCHOWS ARCHIV
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-03
DOI
10.1007/s00428-019-02737-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of Wnt signaling promotes olaparib resistant ovarian cancer
- (2019) Tomomi M. Yamamoto et al. MOLECULAR CARCINOGENESIS
- Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
- (2019) Teeuwssen et al. Journal of Clinical Medicine
- Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics
- (2018) Jaime Prat et al. HUMAN PATHOLOGY
- Wnt signalling in gynaecological cancers: A future target for personalised medicine?
- (2016) C.E. Ford et al. GYNECOLOGIC ONCOLOGY
- Wnt Signaling and Survival of Women With High-Grade Serous Ovarian Cancer
- (2016) Brandon-Luke L. Seagle et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
- (2016) Rebecca C. Arend et al. Oncotarget
- Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974
- (2015) Jonathan D Boone et al. LABORATORY INVESTIGATION
- Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
- (2015) Anil Belur Nagaraj et al. Oncotarget
- Dickkopf-1, the Wnt antagonist, is induced by acidic pH and mediates epithelial cellular senescence in human reflux esophagitis
- (2014) Orestis Lyros et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
- (2014) Lubomir Bodnar et al. Journal of Ovarian Research
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Mitotic and mitogenic Wnt signalling
- (2012) Christof Niehrs et al. EMBO JOURNAL
- Wnt/β-Catenin Pathway Is Regulated by PITX2 Homeodomain Protein and Thus Contributes to the Proliferation of Human Ovarian Adenocarcinoma Cell, SKOV-3
- (2012) Moitri Basu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- WNT7A Regulates Tumor Growth and Progression in Ovarian Cancer through the WNT/ -Catenin Pathway
- (2012) S. Yoshioka et al. MOLECULAR CANCER RESEARCH
- Epigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization
- (2011) Marina Di Domenico et al. CANCER BIOLOGY & THERAPY
- Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
- (2011) W. Dai et al. CLINICAL CANCER RESEARCH
- When pathways collide: collaboration and connivance among signalling proteins in development
- (2010) Helen McNeill et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Novel Role for Wnt/Ca2+ Signaling in Actin Cytoskeleton Remodeling and Cell Motility in Prostate Cancer
- (2010) Qin Wang et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started